Clinical Trials Browser

Phase 2 × Has results × uproleselan × Clear all

NCT04682405 2023-12-15

Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)

Phase 2 Completed

51 enrolled 18 charts

Multiple Myeloma